Comments
Loading...
Neurocrine Biosciences (NASDAQ:NBIX) Stock, Earnings Estimates, EPS, And Revenue
Neurocrine Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 5
EPS Estimate
$1.570
Quarterly Revenue Estimate
$622.2M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$2.2B
Analyze the earnings history of Neurocrine Biosciences using advanced sorting and filters.
Data brought to you by Benzinga APIs
Neurocrine Biosciences (NBIX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-10-30 | $1.81 | $1.51 | 19.9 % |
| Jun 2024 | 2024-08-01 | $1.63 | $1.03 | 58.3 % |
| Mar 2024 | 2024-05-01 | $1.20 | $1.01 | 18.8 % |
| Dec 2023 | 2024-02-07 | $1.54 | $1.15 | 33.9 % |
Neurocrine Biosciences (NBIX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-01 | $590.20M | $547.07M | 7.88 % |
| Mar 2024 | 2024-05-01 | $515.30M | $511.97M | 0.65 % |
| Dec 2023 | 2024-02-07 | $515.20M | $518.13M | -0.57 % |
| Sep 2023 | 2023-10-31 | $498.80M | $469.92M | 6.15 % |
FAQ
When is Neurocrine Biosciences (NASDAQ:NBIX) reporting earnings?
Neurocrine Biosciences (NBIX) is scheduled to report earnings on February 5, 2025. The last reported earnings were for reported on October 30, 2024 for Q3.
What were the latest earnings per share (EPS) for Neurocrine Biosciences (NASDAQ:NBIX)?
The Actual EPS was $1.81, which beat the estimate of $1.51.
What were Neurocrine Biosciences’s (NASDAQ:NBIX) revenues?
The Actual Revenue was $622.1M, which beat the estimate of $600.6M.
Browse earnings estimates, EPS, and revenue on all stocks.